Physician profile
Mark D Flora
NPI 1336126358
$7,799.30
in general payments reported to CMS, 2019-2025
43 companies · $992 in 2025
The $992 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,744 · 2020: $601 · 2021: $910 · 2022: $983 · 2023: $808 · 2024: $762 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,036.19 | 2019 | |
| Sumitomo Pharma America, INC. | $824.85 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $633.95 | 2019-2022 | |
| Pfizer INC. | $579.84 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $425.10 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $323.22 | 2021-2025 | Jelmyto |
| Abbvie INC. | $262.90 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $228.44 | 2020-2025 | Urgent Pc Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $209.54 | 2019-2025 | Adstiladrin |
| Boston Scientific Corporation | $172.55 | 2022-2025 | Spaceoar Vue System - 10ml, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Lithovue |
| Blue Earth Diagnostics | $168.80 | 2021-2023 | |
| Coloplast Corp | $155.43 | 2023-2025 | Porges Coloplast |
| Immunitybio, INC. | $150.33 | 2025 | |
| Janssen Biotech, INC. | $150.09 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $139.59 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Flora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.